García, María G.Carella, AntonellaUrdinguio, Rocío G.Bayón, Gustavo F.Lopez, VirginiaTejedor, Juan RamónSierra, Marta I.García-Toraño, EestelaSantamarina, PabloPérez, Raúl. F.Mangas, CristinaAstudillo, AuroraCorte-Torres, M. DanielaSáenz-de-Santa-María, InésChiara, María-DoloresFernández, Agustín F.Fraga, Mario F.2024-10-312024-10-312018-05-25García, M. G., Carella, A., Urdinguio, R. G., Bayón, G. F., Lopez, V., Tejedor, J. R., Sierra, M. I., García-Toraño, E., Santamarina, P., Perez, R. F., Mangas, C., Astudillo, A., Corte-Torres, M. D., Sáenz-de-Santa-María, I., Chiara, M. D., Fernández, A. F., & Fraga, M. F. (2018). Epigenetic dysregulation of TET2 in human glioblastoma. Oncotarget, 9(40), 25922–25934. https://doi.org/10.18632/oncotarget.2540610.18632/oncotarget.25406https://hdl.handle.net/20.500.14352/109891Ten-eleven translocation (TET) enzymes are frequently deregulated in cancer, but the underlying molecular mechanisms are still poorly understood. Here we report that TET2 shows frequent epigenetic alterations in human glioblastoma including DNA hypermethylation and hypo-hydroxymethylation, as well as loss of histone acetylation. Ectopic overexpression of TET2 regulated neural differentiation in glioblastoma cell lines and impaired tumor growth. Our results suggest that epigenetic dysregulation of TET2 plays a role in human glioblastoma.engAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/journal article1949-2553https://www.oncotarget.com/article/25406/text/29899831https://pubmed.ncbi.nlm.nih.gov/29899831/open access577.25-hydroxymehtylcytosineglioblastomaTET2epigeneticsDNA methylationBiología molecular (Biología)2415 Biología Molecular